SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
25/09/2024 09:15:19 | Var. +0.120 | Volume | Denaro09:15:57 | Lettera09:15:57 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
30.640EUR | +0.39% | - Fatturato: - |
30.640Quantità in denaro: 425 | 30.780Quantità in lettera: 166 | 4.59 bill.EUR | 0.49% | 30.18 |
Newsfile Corp
05:34
Founder of RS Law Group Jason Rabinovich Receives Rising Stars 2016-2024 Award by Super Lawyers
Newsfile Corp
04:31
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of XPEL
Newsfile Corp
03:21
ROSEN, A GLOBAL INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Bef...
Newsfile Corp
03:05
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Late Stage Asset Management, LLC Investors with Losses...